Megan N. Frone

Specifications of the ACMG/AMP variant interpretation guidelines for germline <i>TP53</i> variants

Cristina Fortuño, Kristy Lee, Magali Olivier et al. · Human Mutation · 2020 · 165 citations · Full text

Life Sciences, Genetics, Oncology +17

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Kelvin C. de Andrade, Elaine E. Lee, Elise M. Tookmanian et al. · Cell Death and Differentiation · 2022 · 165 citations · Full text

Medicine, Cancer Biology, Oncology +14

Variable population prevalence estimates of germline <i>TP53</i> variants: A gnomAD-based analysis

Kelvin C. de Andrade, Megan N. Frone, Talía Wegman-Ostrosky et al. · Human Mutation · 2018 · 95 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Advancing <scp>RAS/RASopathy</scp> therapies: An NCI‐sponsored intramural and extramural collaboration for the study of <scp>RASopathies</scp>

Andrea M. Gross, Megan N. Frone, Karen W. Gripp et al. · American Journal of Medical Genetics Part A · 2020 · 63 citations · Full text

Medicine, Neurology, Oncology +17

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study

Jung Kim, Matthew Gianferante, Danielle M. Karyadi et al. · JNCI Cancer Spectrum · 2021 · 47 citations · Full text

Medicine, Genetics, Oncology +17